Gemmer Asset Management’s Charles River Laboratories CRL Stock Holding History

Gemmer Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-156	Closed	-$44K	–	320
2022 Q1	$44K	Hold	156	–	–	0.01%	291
2021 Q4	$59K	Hold	156	–	–	0.01%	238
2021 Q3	$64K	Hold	156	–	–	0.01%	203
2021 Q2	$58K	Hold	156	–	–	0.01%	239
2021 Q1	$45K	Hold	156	–	–	0.01%	272
2020 Q4	$39K	Hold	156	–	–	0.01%	274
2020 Q3	$35K	Hold	156	–	–	0.01%	266
2020 Q2	$27K	Hold	156	–	–	0.01%	306
2020 Q1	$20K	Sell	156 -18	-10%	-$2.7K	0.01%	327
2019 Q4	$27K	Hold	174	–	–	0.01%	309
2019 Q3	$23K	Hold	174	–	–	0.01%	351
2019 Q2	$25K	Hold	174	–	–	0.01%	319
2019 Q1	$25K	Buy	174 +18	+12%	+$2.37K	0.01%	336
2018 Q4	$18K	Hold	156	–	–	0.01%	387
2018 Q3	$21K	Hold	156	–	–	0.01%	384
2018 Q2	$18K	Hold	156	–	–	0.01%	440
2018 Q1	$17K	Hold	156	–	–	0.01%	461
2017 Q4	$17K	Hold	156	–	–	0.01%	477
2017 Q3	$17K	Hold	156	–	–	0.01%	431
2017 Q2	$16K	Hold	156	–	–	0.01%	443
2017 Q1	$14K	Hold	156	–	–	0.01%	496
2016 Q4	$12K	Hold	156	–	–	0.01%	528
2016 Q3	$13K	Hold	156	–	–	0.01%	470
2016 Q2	$13K	Sell	156 -62	-28%	-$5.11K	0.01%	447
2016 Q1	$16K	Hold	218	–	–	0.01%	370
2015 Q4	$18K	Hold	218	–	–	0.01%	324
2015 Q3	$14K	Hold	218	–	–	0.01%	420
2015 Q2	$15K	Hold	218	–	–	0.01%	407
2015 Q1	$17K	Hold	218	–	–	0.01%	378
2014 Q4	$14K	Hold	218	–	–	0.01%	434
2014 Q3	$13K	Hold	218	–	–	0.01%	441
2014 Q2	$12K	Hold	218	–	–	0.01%	502
2014 Q1	$13K	Buy	+218	New	+$12.7K	0.01%	446

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gemmer Asset Management's CRL Position: Q2 2022 in Review

Gemmer Asset Management sold out of Charles River Laboratories (CRL) in Q2 2022, closing a stake of 156 shares — an estimated $44K sold.

Gemmer Asset Management first reported a position in CRL in Q1 2014 and held it in 33 quarters. The position peaked at $64K in Q3 2021. 627 funds tracked by Wall St. Rank hold CRL as of Q2 2022.

Gemmer Asset Management reported no remaining Charles River Laboratories position as of Q2 2022 after selling out during the quarter.
Gemmer Asset Management sold 156 Charles River Laboratories shares in Q2 2022, an estimated $44K.
Gemmer Asset Management first reported a position in Charles River Laboratories in Q1 2014 and held it in 33 quarters.
Gemmer Asset Management's Charles River Laboratories position peaked at $64K in Q3 2021.
627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.